Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 275 entries
View as:

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.

Phase: N/A Priority: Normal
NCT ID: NCT01101776 Org: User:
Start: 01/31/10 End: 04/30/13 Due: 04/30/14

Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients

Phase: N/A Priority: Normal
NCT ID: NCT01082757 Org: User:
Start: 06/30/09 End: 08/31/13 Due: 08/31/14

MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02699515 Org: User:
Start: 03/11/16 End: 02/21/22 Due: 02/21/23

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

Phase: N/A Priority: Normal
NCT ID: NCT01142518 Org: User:
Start: 07/31/05 End: 03/31/09 Due: 03/31/10

Neuropathic Pain Management

Phase: N/A Priority: Normal
NCT ID: NCT01263132 Org: User:
Start: 02/29/08 End: 02/28/10 Due: 02/28/11

Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)

Phase: N/A Priority: Normal
NCT ID: NCT03858049 Org: User:
Start: 05/31/19 End: 10/27/21 Due: 10/27/22

Oral Bioavailability and Mass Balance Trial With Pimasertib

Phase: N/A Priority: Normal
NCT ID: NCT01713036 Org: User:
Start: 11/30/12 End: 07/31/14 Due: 07/31/15

Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00911469 Org: User:
Start: 11/30/07 End: 06/30/10 Due: 06/30/11

Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00113581 Org: User:
Start: 10/31/02 End: 01/31/07 Due: 01/31/08

Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01601119 Org: User:
Start: 01/31/12 End: 07/31/14 Due: 07/31/15

Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02252965 Org: User:
Start: 12/31/14 End: 04/30/16 Due: 04/30/17

A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00287118 Org: User:
Start: 10/27/04 End: 05/30/06 Due: 05/30/07

Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants

Phase: N/A Priority: Normal
NCT ID: NCT03010423 Org: User:
Start: 11/30/16 End: 07/09/19 Due: 07/09/20

A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01074307 Org: User:
Start: 10/31/09 End: 08/31/12 Due: 08/31/13

EXpression PRofile Endometrium Samples Study

Phase: N/A Priority: Normal
NCT ID: NCT01210144 Org: User:
Start: 08/31/08 End: 08/31/10 Due: 08/31/11

A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02064816 Org: User:
Start: 05/31/14 End: 04/30/16 Due: 04/30/17

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Phase: N/A Priority: Normal
NCT ID: NCT01081639 Org: User:
Start: 11/30/03 End: 09/30/04 Due: 09/30/05

A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients

Phase: N/A Priority: Normal
NCT ID: NCT01228734 Org: User:
Start: 09/09/10 End: 01/31/18 Due: 01/31/19

Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01104558 Org: User:
Start: 12/31/08 End: 07/31/10 Due: 07/31/11

Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)

Phase: N/A Priority: Normal
NCT ID: NCT02394782 Org: User:
Start: 02/28/15 End: 03/31/16 Due: 03/31/17

Effect of Renal Impairment on Evobrutinib Pharmacokinetics (PK)

Phase: N/A Priority: Normal
NCT ID: NCT03436394 Org: User:
Start: 03/21/18 End: 02/22/19 Due: 02/22/20

Effects of Cladribine Tablets on the PK of Microgynon®

Phase: N/A Priority: Normal
NCT ID: NCT03745144 Org: User:
Start: 01/17/19 End: 09/16/22 Due: 09/16/23

An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)

Phase: N/A Priority: Normal
NCT ID: NCT02806232 Org: User:
Start: 06/12/16 End: 11/17/18 Due: 11/17/19

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization

Phase: N/A Priority: Normal
NCT ID: NCT01183143 Org: User:
Start: 05/11/04 End: 03/02/06 Due: 03/02/07

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

Phase: N/A Priority: Normal
NCT ID: NCT01079949 Org: User:
Start: 11/30/07 End: 10/31/10 Due: 10/31/11